Breadcrumb Home investors intimation stock exchanges Intimation to stock Exchanges Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-20162014-20152013-20142012-20132011-20122010-2011 Apply Notice of 84th AGM and E-voting Information – Newspaper Publication 06th Aug 2020 Notice of 84th Annual General Meeting of Cipla Limited 05th Aug 2020 Notice of Book Closure – Newspaper Publication 03rd Aug 2020 84th Annual General Meeting – Newspaper Publication 01st Aug 2020 Revised Earnings Conference Call 29th Jul 2020 Earnings Conference Call 28th Jul 2020 Secretarial Compliance Report 27th Jul 2020 Clarification on news item appearing in the “Newspaper-The Economic Times” dated July 23, 2020 captioned “Cipla all set to launch Favipiravir drug for treatment of COVID patients (Article). 26th Jul 2020 Press Release – Cipla receives regulatory approval for launch of Ciplenza (Favipiravir 200 mg) in India to treat mild to moderate COVID-19 24th Jul 2020 Amalgamation of a wholly owned step down subsidiary, Cipla Pharma Lanka (Private) Limited with Company’s another wholly owned step-down subsidiary, Breathe Free Lanka (Private) Limited 22nd Jul 2020 Pagination First page first Previous page ‹ Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 Next page › Last page last BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
